Source:http://linkedlifedata.com/resource/pubmed/id/19343742
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2009-5-4
|
pubmed:abstractText |
RAR and RXR agonists: A collection of pyrazine-based RAR/RXR ligands were prepared by a series of palladium catalyzed cross-coupling reactions and characterized. Structure-activity relationships were elucidated. Retinoic acid receptor (RAR) alpha/beta-subtype-selective and retinoid X receptor (RXR) inverse agonist activities are described for pyrazine acrylic acid arotinoid, 14 d. Heterocyclic arotinoids derived from central-region dihalogenated pyrazine scaffolds have been synthesized by consecutive halogen and/or position-selective palladium-catalyzed cross-coupling reactions. Pyrazines were further functionalized as alkyl ethers or methylamines prior to the last Pd-catalyzed reactions. Transient transactivation studies with the retinoic acid receptor (RAR) alpha, beta, and gamma subtypes and with retinoid X receptor (RXR) alpha revealed distinct agonist, antagonist, and inverse agonist activities for these compounds. Of interest are the RARalpha,beta-selective inverse agonists with pyrazine acrylic acid structures, in particular 14 c, which is RARbeta-selective, and 14 d, a pan-RAR/RXR inverse agonist with more affinity for the RAR subtypes that enhance the interaction of RAR with cognate corepressors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Retinoic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Retinoid X Receptor alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Retinoids
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1439-7633
|
pubmed:author |
pubmed-author:BourguetWilliamW,
pubmed-author:CollettePascalP,
pubmed-author:ErbCathieC,
pubmed-author:GarcíaJoséJ,
pubmed-author:GronemeyerHinrichH,
pubmed-author:KhanwalkarHarshalH,
pubmed-author:MauvaisPascaleP,
pubmed-author:PereiraRaquelR,
pubmed-author:VoegelJohannes JJJ,
pubmed-author:de LeraAngel RAR
|
pubmed:issnType |
Electronic
|
pubmed:day |
4
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1252-9
|
pubmed:meshHeading |
pubmed-meshheading:19343742-Drug Inverse Agonism,
pubmed-meshheading:19343742-Ligands,
pubmed-meshheading:19343742-Pyrazines,
pubmed-meshheading:19343742-Receptors, Retinoic Acid,
pubmed-meshheading:19343742-Retinoid X Receptor alpha,
pubmed-meshheading:19343742-Retinoids,
pubmed-meshheading:19343742-Two-Hybrid System Techniques
|
pubmed:year |
2009
|
pubmed:articleTitle |
Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
|
pubmed:affiliation |
Departamento de Química Orgánica, Universidade de Vigo, Lagoas-Marcosende, 36310 Vigo, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|